Diagnostic value of anti-Müllerian hormone combined with androgen-levels in Chinese patients with polycystic ovary syndrome

References

• Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome, nature reviews. Dis Primers. 2016;2:1.
   Web of Science ®Google Scholar
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility Sterility. 2004;81:19–7.
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism. 2019;92:108–120.
   PubMed Web of Science ®Google Scholar
• Moran LJ, Brown WJ, McNaughton SA, et al. Weight management practices associated with PCOS and their relationships with diet and physical activity. Hum Reprod. 2017;32(3):669–678.
   PubMed Web of Science ®Google Scholar
• Szczuko M, Kikut J, Szczuko U, et al. Nutrition strategy and life style in polycystic ovary syndrome-narrative review. Nutrients. 2021;13(7):2452.
   PubMed Web of Science ®Google Scholar
• Osibogun O, Ogunmoroti O, Michos ED. Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention. Trends Cardiovasc Med. 2020;30(7):399–404.
   PubMed Web of Science ®Google Scholar
• Bozdag G, Mumusoglu S, Zengin D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–2855.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284.
   PubMed Web of Science ®Google Scholar
• Detti L, Fletcher NM, Saed GM, et al. Anti-Müllerian hormone (AMH) may stall ovarian cortex function through modulation of hormone receptors other than the AMH receptor. Reprod Sci. 2018;25(8):1218–1223.
   PubMed Web of Science ®Google Scholar
• Moolhuijsen LME, Visser JA. Anti-Müllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab. 2020;105(11):3361–3373.
   PubMed Web of Science ®Google Scholar
• Dumont A, Robin G, Dewailly D. Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome. Curr Opin Endocrinol Diabetes Obes. 2018;25(6):377–384.
   PubMedGoogle Scholar
• Jacobs MH, Reuter LM, Baker VL, et al. A multicentre evaluation of the Elecsys(®) anti-Müllerian hormone immunoassay for prediction of antral follicle count. Reprod Biomed Online. 2019;38(5):845–852.
   PubMed Web of Science ®Google Scholar
• Cimino I, Casoni F, Liu X, et al. Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun. 2016;7:10055.
   PubMed Web of Science ®Google Scholar
• Evliyaoglu O, Imöhl M, Weiskirchen R, et al. Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome. Clin Chem Lab Med. 2020;58(8):1291–1301.
   PubMed Web of Science ®Google Scholar
• Abbara A, Eng PC, Phylactou M, et al. Anti-Müllerian hormone (AMH) in the diagnosis of menstrual disturbance due to polycystic ovarian syndrome. Front Endocrinol (Lausanne). 2019;10:656.
   PubMed Web of Science ®Google Scholar
• Alebic M, Stojanovic N, Dewailly D. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues. Hum Reprod. 2018;33(6):1141–1148.
   PubMed Web of Science ®Google Scholar
• Tian X, Ruan X, Mueck AO, et al. Anti-Müllerian hormone levels in women with polycystic ovarian syndrome compared with normal women of reproductive age in China. Gynecol Endocrinol. 2014;30(2):126–129.
   PubMed Web of Science ®Google Scholar
• Li Y, Ruan X, Wang H, et al. Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment. Fertil Steril. 2018;109(4):720–727.
   PubMed Web of Science ®Google Scholar
• Cedars MI. Evaluation of female fertility-AMH and ovarian reserve testing. J Clin Endocrinol Metab. 2022;107(6):1510–1519.
   PubMed Web of Science ®Google Scholar
• Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reprod (Oxford, England). 2018;33(9):1602–1618.
   PubMed Web of Science ®Google Scholar
• Teede H, Misso M, Tassone EC, et al. Anti-Müllerian hormone in PCOS: a review informing international guidelines. Trends Endocrinol Metab. 2019;30(7):467–478.
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666–3672.
   PubMed Web of Science ®Google Scholar
• Dietz de Loos A, Hund M, Buck K, et al. Antimüllerian hormone to determine polycystic ovarian morphology. Fertil Steril. 2021;116(4):1149–1157.
   PubMed Web of Science ®Google Scholar
• Tal R, Seifer DB, Khanimov M, et al. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes. Am J Obstet Gynecol. 2014;211(1):e51-58–59.e8. 59.
   Web of Science ®Google Scholar
• Wongwananuruk T, Panichyawat N, Indhavivadhana S, et al. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women. Taiwan J Obstet Gynecol. 2018;57(4):499–506.
   PubMed Web of Science ®Google Scholar
• Mimouni NEH, Paiva I, Barbotin AL, et al. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell Metab. 2021;33(3):513–530.e8. e518.
   PubMed Web of Science ®Google Scholar
• Crisosto N, Ladrón de Guevara A, Echiburú B, et al. Higher luteinizing hormone levels associated with antimüllerian hormone in postmenarchal daughters of women with polycystic ovary syndrome. Fertil Steril. 2019;111(2):381–388.
   PubMed Web of Science ®Google Scholar
• Risal S, Pei Y, Lu H, et al. Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nat Med. 2019;25(12):1894–1904.
   PubMed Web of Science ®Google Scholar
• Tata B, Mimouni NEH, Barbotin AL, et al. Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med. 2018;24(6):834–846.
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab. 2006;91(11):4237–4245.
   PubMed Web of Science ®Google Scholar
• Goodman NF, Cobin RH, Futterweit W, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome–part 1. Endocr Pract. 2015;21(11):1291–1300.
   PubMed Web of Science ®Google Scholar
• Silvestris E, de Pergola G, Rosania R, et al. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16(1):22.
   PubMed Web of Science ®Google Scholar